These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
333 related articles for article (PubMed ID: 31926503)
1. Evaluation of Serum β2-microglobulin in Egyptian Patients with Systemic Lupus Erythematosus. Abd-Elbaky NM; Albeltagy ES; Hammour AE; Ibrahim AS Egypt J Immunol; 2019 Jul; 26(2):143-153. PubMed ID: 31926503 [TBL] [Abstract][Full Text] [Related]
2. β2-microglobulin as a marker of systemic lupus erythematosus activity. Żychowska I; Suszek D; Dryglewska M; Majdan M Adv Clin Exp Med; 2018 Mar; 27(3):379-382. PubMed ID: 29533541 [TBL] [Abstract][Full Text] [Related]
3. Urine β2-microglobulin is associated with clinical disease activity and renal involvement in female patients with systemic lupus erythematosus. Choe JY; Park SH; Kim SK Lupus; 2014 Dec; 23(14):1486-93. PubMed ID: 25124677 [TBL] [Abstract][Full Text] [Related]
4. Beta 2-microglobulin can be a disease activity marker in systemic lupus erythematosus. Kim HA; Jeon JY; Yoon JM; Suh CH Am J Med Sci; 2010 Apr; 339(4):337-40. PubMed ID: 20186038 [TBL] [Abstract][Full Text] [Related]
5. Serum neopterin, tumor necrosis factor-alpha and soluble tumor necrosis factor receptor II (p75) levels and disease activity in Egyptian female patients with systemic lupus erythematosus. Mahmoud RA; El-Gendi HI; Ahmed HH Clin Biochem; 2005 Feb; 38(2):134-41. PubMed ID: 15642275 [TBL] [Abstract][Full Text] [Related]
6. Assessment of Interleukin 17 in Egyptian Systemic Lupus Erythematosus Patients as a Biomarker in Disease Activity. Behiry M; Wadie M; Mohamed NA; Farid R; Ramadan H Curr Rheumatol Rev; 2024; 20(5):534-543. PubMed ID: 38299415 [TBL] [Abstract][Full Text] [Related]
7. Systemic lupus erythematosus activity and beta two microglobulin levels. Skare TL; Ferri K; Santos MA Sao Paulo Med J; 2014; 132(4):239-42. PubMed ID: 25055070 [TBL] [Abstract][Full Text] [Related]
8. Soluble TNF-R1, VEGF and other cytokines as markers of disease activity in systemic lupus erythematosus and lupus nephritis. Adhya Z; El Anbari M; Anwar S; Mortimer A; Marr N; Karim MY Lupus; 2019 May; 28(6):713-721. PubMed ID: 31046570 [TBL] [Abstract][Full Text] [Related]
9. Serum β2-microglobulin level is a useful indicator of disease activity and hemophagocytic syndrome complication in systemic lupus erythematosus and adult-onset Still's disease. Wakabayashi K; Inokuma S; Matsubara E; Onishi K; Asashima H; Nakachi S; Hagiwara K Clin Rheumatol; 2013 Jul; 32(7):999-1005. PubMed ID: 23504210 [TBL] [Abstract][Full Text] [Related]
10. Measurement of serum interferon alpha in Egyptian patients with systemic lupus erythematosus and evaluation of its effect on disease activity: a case-control study. Fayed A; El Menyawi MM; Ghanema M; Shaker O; Elgohary R Reumatismo; 2020 Nov; 72(3):145-153. PubMed ID: 33213127 [TBL] [Abstract][Full Text] [Related]
11. Serum uric acid as a predictor for nephritis in Egyptian patients with systemic lupus erythematosus. Hafez EA; Hassan SAE; Teama MAM; Badr FM Lupus; 2021 Mar; 30(3):378-384. PubMed ID: 33323012 [TBL] [Abstract][Full Text] [Related]
12. Elevated serum interleukin-34 level in juvenile systemic lupus erythematosus and disease activity. El-Banna HS; El Khouly RM; Gado SE Clin Rheumatol; 2020 May; 39(5):1627-1632. PubMed ID: 31907692 [TBL] [Abstract][Full Text] [Related]
14. High serum leptin and adiponectin levels as biomarkers of disease progression in Egyptian patients with active systemic lupus erythematosus. Kamel SM; Abdel Azeem Abd Elazeem MEMI; Mohamed RA; Kamel MM; Abdel Aleem Abdelaleem EA Int J Immunopathol Pharmacol; 2023; 37():3946320231154988. PubMed ID: 36718110 [No Abstract] [Full Text] [Related]
15. CXCL13 is an activity marker for systemic, but not cutaneous lupus erythematosus: a longitudinal cohort study. Niederkorn A; Frühauf J; Schwantzer G; Wutte N; Painsi C; Werner S; Stradner M; Berghold A; Hermann J; Aberer E Arch Dermatol Res; 2018 Aug; 310(6):485-493. PubMed ID: 29728857 [TBL] [Abstract][Full Text] [Related]
16. Serum ferritin level correlates with SLEDAI scores and renal involvement in SLE. Tripathy R; Panda AK; Das BK Lupus; 2015 Jan; 24(1):82-9. PubMed ID: 25253568 [TBL] [Abstract][Full Text] [Related]
17. Increased serum β2-microglobulin is associated with clinical and immunological markers of disease activity in systemic lupus erythematosus patients. Hermansen ML; Hummelshøj L; Lundsgaard D; Hornum L; Keller P; Fleckner J; Fox B; Poulsen LK; Jacobsen S Lupus; 2012 Sep; 21(10):1098-104. PubMed ID: 22577117 [TBL] [Abstract][Full Text] [Related]
18. Serum phosphatidylserine-specific phospholipase A Sawada T; Kurano M; Shirai H; Iwasaki Y; Tahara K; Hayashi H; Igarashi K; Fujio K; Aoki J; Yatomi Y Int J Rheum Dis; 2019 Nov; 22(11):2059-2066. PubMed ID: 31468739 [TBL] [Abstract][Full Text] [Related]
19. Lymphocytotoxic antibodies in systemic lupus erythematosus are associated with disease activity irrespective of the presence of neuropsychiatric manifestations. Magalhães MB; da Silva LM; Voltarelli JC; Donadi EA; Louzada-Junior P Scand J Rheumatol; 2007; 36(6):442-7. PubMed ID: 18092265 [TBL] [Abstract][Full Text] [Related]
20. Serum free light chains as biomarkers for systemic lupus erythematosus disease activity. Aggarwal R; Sequeira W; Kokebie R; Mikolaitis RA; Fogg L; Finnegan A; Plaas A; Block JA; Jolly M Arthritis Care Res (Hoboken); 2011 Jun; 63(6):891-8. PubMed ID: 21312346 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]